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Abstract  
Small heat shock proteins are ATP-independent molecular chaperones. Their function is to 
bind partially unfolded proteins under stress conditions. In vivo, members of this chaperone 
family are known to preferentially assemble together forming large, polydisperse 
heterooligomers. The exact molecular mechanisms that drive specific heteroassociation are 
currently unknown. Here we study the oligomers formed between human HSPB1 and HSPB6. 
Using small-angle X-ray scattering we could characterize two distinct heterooligomeric 
species present in solution. By employing native mass spectrometry we show that such 
assemblies are formed purely from heterodimeric building blocks, in line with earlier cross-
linking studies. Crucially, a detailed analysis of truncation variants reveals that the 
preferential association between these two sHSPs is solely mediated by their disordered N-
terminal domains. 
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Small heat shock proteins (sHSPs) are an important family of chaperones involved in 
the protein quality control network [1,2]. Functioning in a fully ATP-independent manner, 
sHSPs detect and capture partially unfolded protein species, maintaining such entities in a 
soluble state [3,4]. Although sHSPs have a low monomeric molecular weight (typically 
around 20kDa), the majority of members of this family form high molecular weight 
polydisperse oligomers that demonstrate rapid subunit turnover [3,5]. Adding to this structural 
complexity it is also recognized that sHSP orthologues within an organism can form 
heterooligomers [6–8]. The differential structure and activity of such entities though is poorly 
understood. 
Humans encode ten sHSP homologues [9], several of which are known to form 
heterooligomers [10,11]. The best characterized heteroassembly is g-crystallin, a complex 
comprised of a 3:1 ratio of gA- and gB-crystallin [12,13]. Although present in this proportion 
in most vertebrate lenses, in vitro these two sHSPs form mixed oligomers with subunit ratios 
that reflect the amount of each used [14,15]. Contrasting with this behavior, certain sHSPs 
form heterooligomers that are always composed of a fixed proportion of the constituent 
chains. For instance when co-expressed HSPB2 and HSPB3 form heterocomplexes containing 
the respective sHSPs in a strict 3:1 ratio [16].  
In this study we focus on the complex formed between human HSPB1 and HSPB6. 
These two sHSPs are both highly expressed in muscle tissue, alongside HSPB2 and HSPB5 
[17].  Indeed, HSPB1 and HSPB6 were originally identified as a co-purifying contaminants, 
when isolating HSPB5 from human, bovine and rat skeletal muscle [18,19]. Alone these two 
sHSPs are found as distinctly different assemblies. HSPB1 forms large oligomers, typically 
observed amongst representatives of this family of chaperones, while HSPB6 only forms 
dimers in solution [14,20–22]. Previous studies of the heterooligomers formed between 
recombinant HSPB1 and HSPB6 have shown that they are considerably more polydisperse in 
size than the component sHSPs, with a molecular weight that spans the range between the two 
individual proteins [21]. The heterooligomer is composed of equimolar amounts of each 
sHSP, a relative ratio that is fixed independent of the amount of each sHSP added to the 
mixture [23]. Importantly, studies using disulphide cross-linking have shown that these 
oligomers are principally composed of heterodimers suggesting a preferential association of 
HSPB1 and HSPB6  [11,23].  
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Currently the driving force behind the specific subunit dimerization of HSPB1 and 
HSPB6 is unknown. Here, we employ a variety of biophysical techniques such as size-
exclusion chromatography (SEC), small-angle X-ray scattering (SAXS) and native mass 
spectrometry (MS) to fully characterize the biophysical properties of the HSPB1/HSPB6 
heterocomplex at physiologically relevant temperatures. By using truncations, we also show 
that the NTDs of these proteins, regions that are typically viewed as poorly conserved and 
unstructured, are essential for dictating the specific association between HSPB1 and HSPB6. 
 
2. Materials and methods 
 
2.1 Mutagenesis and cloning  
The previously described small ubiquitin modifier (SUMO) fusions of human HSPB1 
and HSPB6 [24] were used as a PCR template for the generation of the two N-terminal 
deletion constructs. His-tagged SUMO fusion expression constructs corresponding to residues 
92 to 205 of HSPB1 (HSPB1〉N) and residues 72 to 160 of HSPB6 (HSPB6〉N) were created 
by cloning the amplified target sequence into pETHSUL [25] using the In-Fusion® cloning 
kit (Clontech Laboratories). ACD constructs of both HSPB1 and HSPB6 have been reported 
earlier [24]. All constructs were designed such that, upon cleavage of the linearly fused 
SUMO chimera with recombinantly produced SUMO specific hydrolase, no additional non-
native residues would be present on the target protein. 
 
2.2 Expression and purification 
Wild type HSPB1 and HSPB6, the ACD and N-terminal deletion constructs were all 
expressed as previously described [25,26]. Briefly, the constructs were transformed into the E. 
coli Rosetta 2 (DE3) pLysS strain and clones were cultured in ZYP-5052 auto-inducing 
medium [27] using described conditions [24]. Cells were harvested by centrifugation at 
8000g, and resuspended in IMAC12.5 buffer (50 mM sodium phosphate, 250 mM sodium 
chloride and 12.5 mM imidazole, pH7.5) and stored at -80°C until further workup. For the 
expression of 15N-labeled proteins, transformed clones were cultured in 2 mL of LB medium 
for 7h. This culture was then transferred to 50 mL of P0.5G-medium [27] and grown 
overnight at 25°C. 10 mL of this culture was spun down at 3000g and the pellet was 
transferred to 200 mL of auto-inducing minimal medium containing 15N-ammonium chloride 
[27]. Cells were grown and harvested using the same protocol as the richer ZYP-5052 media. 
 Cells were thawed and diluted further in IMAC12.5 buffer complemented with 1 
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unit/mL of Cryonase Cold Active Nuclease (Clontech Laboratories) and 10 mM MgCl2. Cells 
were lysed by three rounds of sonication, with a 20 min incubation period between each cycle 
at 4°C. Following clarification of the lysate by centrifugation at 18,000g for 1 hr at 4°C, each 
target fusion was purified from the supernatant by subtractive immobilized-metal affinity 
chromatography (IMAC), ion exchange and size exclusion chromatography (SEC) using the 
previously described protocols [25,26]. The 15N-labeled constructs were purified using the 
same procedures except the final SEC step was performed using a Superdex 200 10/300 GL 
column pre-equilibrated in 200 mM ammonium acetate pH 6.9 containing 2.5 mM DTT. 
 
2.3 Formation of heterooligomeric complexes 
For all analyses, recombinant HSPB1 and HSPB6 were mixed in an equimolar ratio 
based on their monomeric molecular weight and incubated overnight at 37°C to allow 
complete subunit exchange. For size-exclusion chromatography, 220 μM (corresponding to 5 
mg/ml for HSPB1) of each protein was mixed in 20 mM HEPES pH 7.4, 150 mM NaCl and 
10mM DTT prior to incubation.  
 For the native mass spectrometry experiments, 200 μM of each protein (monomer 
concentration) was mixed in 200 mM aqueous ammonium acetate buffer pH 6.9. All 
complexes were formed by overnight incubation at 37°C and were further dialyzed into the 
same ammonium acetate buffer containing 2.5 mM DTT to ensure complete removal of any 
nonvolatile salt. Samples were diluted in the same buffer to the appropriate concentration 
before analysis. 
 
2.4 Analytical size-exclusion chromatography 
100 μL of each protein or complex was loaded onto a Superdex 200 10/300 GL 
column (GE Healthcare Life Sciences), pre-equilibrated at 4°C in 20 mM HEPES pH 7.4, 150 
mM NaCl and 2.5 mM DTT using a flow-rate of 0.5 mL/min. The column was calibrated 
using standards from the Molecular Weight Calibration kit from GE Healthcare Life Sciences. 
Blue dextran, ferritin, aldolase, conalbumin, ovalbumin, carbonic anhydrase, ribonuclease A 
and aprotinin were diluted in the same buffer and run under the same conditions. 
 
2.5 SEC-coupled small-angle X-ray scattering 
 SEC-coupled small-angle X-ray scattering (SAXS) measurements were performed on 
the SWING beamline at Soleil Synchrotron (Gif-sur-Yvette, France) [28]. The individual 
sHSPs or the heterooligomeric mixture, prepared as described above, were loaded onto an 
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Agilent Bio SEC-3 4.6 mm by 300 mm column, with a 300 Å pore size and 3 micron bead 
size. The column was pre-equilibrated in 20 mM Hepes pH 7.4, 150 mM NaCl and 2.5 mM 
DTT and separation was performed at 0.2 ml/min. For the different temperature runs the 
autosampler plate, column jacket and the sample flow cell were incubated at the stated values 
for a minimum of 30 minutes prior to sample loading. 
For each run 100 SAXS frames, measured following sample injection but preceding 
the column void volume, were collected for buffer subtraction. 250 sample frames where 
collected during the elution phase. In both cases the eluate was exposed to the X-ray beam for 
1500 ms with a gap time of 500 ms between frames. Radial averaging of the collected frames, 
buffer averaging and subsequent subtraction from the sample data were performed using the 
Foxtrot application (SWING beamline). Further analysis was performed using the HPLC-
SAXS module within the UltraScan Solution Modeler software package [29]. Scattering 
intensity profiles were generated by converting the I(q) data for each frame to an I(t) plot, 
where the measured intensity for each q-value was plotted against the frame number. From 
this plot the five curves for lowest q-values were scaled to the curve with the highest intensity 
and then averaged. For Gaussian fitting of the I(t) plot a hybrid EMG+GMG function was 
employed. Peak positions were initially set based on their position in UV chromatogram. 
These values were only allowed to shift by 1% during refinement of the Gaussian function.  
The molecular weight of the scattering species at a specific elution position was 
determined using the calculated QR mass parameter performed in the program ScÅtter [30]. . 
The I(q) data corresponding to the frame at the peak maxima in the I(t) plot, and the two 
frames either side were opened and compared to ensure similarity. These curves were then 
scaled together and averaged. The averaged curve was employed to calculate the Rg and 
volume-of-correlation (Vc), both necessary to determine QR.  
 
2.6 Native mass spectrometry 
 All MS measurements were performed on a quadrupole/ion mobility/time-of-flight 
instrument (Synapt G2 HDMS, Waters, Milford, US) [31], operated in positive ion mode. 
Data acquisition and processing were performed using MassLynx (version 4.1) and external 
calibration up to 5000 m/z was performed with CsI solution. For native MS analyses, 
approximately 5 μL of solution containing 20 μM of protein (monomer concentration) in 200 
mM ammonium acetate pH 6.9 containing 2.5 mM DTT was transferred to gold-coated 
capillaries prepared in-house and infused into the mass spectrometer using the nanoflow 
version of the Z-spray ion source. A capillary voltage of 1.0 – 1.3 kV and minimal (<0.2 bar) 
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nanoflow gas pressure were used, and the instrument was operated in Mobility/Sensitivity 
mode. Instrument parameters were as follows unless stated otherwise: sample cone 80 V, 
extraction cone 1 V, backing pressure 3.2 – 4.5 mbar, source pressure 4.6e-3 – 5.8e-3 mbar, 
trap collision energy 10 V, trap DC bias 50 V, transfer collision energy 5 V. 
 
2.7 Chaperone assay 
 The sHSPs were assessed for their chaperoning capabilities as described previously 
[26]. Briefly, the substrate proteins hen egg-white lysozyme (HEWL, Mr=14313.1 Da), yeast 
alcohol dehydrogenase (yADH, monomer Mr=36760.0 Da) and human insulin (monomer 
Mr=5795.6 Da) were resuspended from a lyophilized powder and dialysed against 50 mM 
phosphate buffer pH 7.5, 100 mM NaCl. These were then incubated, in the same buffer, at a 
final concentration of 0.25 mg/ml with differing amounts of HSPB1, HSPB6 or an equimolar 
mix of the two sHSPs. The calculated substrate:sHSP ratio was based on the monomer 
molecular weight of each substrate, HSPB1 (Mr= 22782.5 Da) and HSPB6 (Mr=17135.6 Da), 
or the average molecular weight of HSPB1 and HSPB6 combined for the heterooligomeric 
mix. Aggregation of insulin and HEWL was induced by the addition of 10 mM DTT at 37°C. 
For yADH 20 mM DTT and 2 mM EDTA was added and the mixture incubated at 42°C. 






3.1 Activity of recombinantly produced sHSPs 
It was previously reported that HSPB1 and HSPB6, when mixed in an equimolar 
fashion, form a broad polydisperse population. These earlier experiments were carried out 
using recombinant protein that was purified by ammonium sulfate fractionation followed by 
anion exchange chromatography and hydrophobic interaction or SEC [21,23]. As we isolated 
the protein using the SUMO fusion technology, it was initially investigated whether these 
results could be replicated. Analysis of the heterooligomeric complex by analytical SEC at 
4°C showed a polydisperse mixture containing two main peaks around 508 and 166 kDa (Fig. 
1A). SDS-PAGE analysis of the eluted fractions showed a 1:1 ratio of both sHSPs across the 
whole chromatogram (Fig. 1B), in line with earlier data [23].  
In addition to examining the solution properties, the chaperone activity of the 
heterooligomeric species formed between recombinant HSPB1 and HSPB6 was also assessed. 
Using reduced insulin as a substrate the heterooligomer showed an increased capacity to 
prevent aggregation when compared to the component sHSPs alone at all ratios tested (Fig. 
1C and Supplemental Fig. 1). With yADH the sHSP mixture demonstrated a small 
enhancement in chaperone-like activity that was most significant at the 10:1 ratio between 
yADH and the two sHSPs combined (Fig. 1D and Supplemental Fig. 1). Finally, using HEWL 
as a substrate, the heterooligomer demonstrated activity that was intermediate of HSPB1 and 
HSPB6 alone (Fig. 1E and Supplemental Fig. 1). Notably, as previously reported, HSPB6 
appears to co-aggregate with denatured lysozyme [26]. By pre-mixing HSPB1 and HSPB6 
together this is prevented, but it results in a mild reduction in chaperone-like activity relative 
to HSPB1 alone for all substrate:sHSP concentration ratios tested.     
 
3.2 SEC-coupled SAXS characterization   
To obtain a better understanding of the biophysical properties of the different 
heterooligomeric species observed in analytical SEC a similarly prepared sample was also 
examined by SEC-coupled SAXS. In this case the heterooligomer was also examined by 
loading equivalent sample volumes, of the same pre-incubated mixture, diluted to different 
concentrations onto the column (Fig. 2A). As before a UV-chromatogram composed of two 
overlapping peaks was observed but, at lower concentrations, the ratio of the two peaks 
changed, with the lower molecular weight species becoming more dominant. Examination of 
the plots of scattering intensity versus elution time shows a similar result, albeit the larger, 
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earlier eluting species dominates the profile resulting in lower resolution between the two 
species (Fig. 2B). For all three loaded concentrations the calculated radius of gyration (Rg) 
across the whole SAXS elution profile are similar. This suggests that while the distribution of 
the different species depends on the protein concentration, the sizes of the component entities 
remain equivalent. Taking this into account, the SAXS data from the middle concentration 
was decomposed using two skewed Gaussians (Fig. 2C). Using the SAXS curves from the 
maxima of the decomposed Gaussian peaks a molecular weight of 306.9 and 95.2 kDa was 
determined based on the calculated QR parameter [30]. These values are equivalent to 
heterooligomeric assemblies with an average number of subunits of 15 and 4, respectively.   
As the above experiments were performed at 15°C, we also investigated the effect of 
temperature on the relative distribution of the heterooligomeric assemblies formed between 
HSPB1 and HSPB6 using SEC-coupled SAXS (Fig. 3). For comparison the two sHSPs were 
also individually run under the same conditions. For HSPB1 and HSPB6 alone, raising the 
temperature to a physiologically relevant value had an opposite effect. In the case of HSPB1 
the protein eluted earlier from the Bio SEC-3 column, while HSPB6 showed a 2.5 minute 
delay in exiting the column upon raising the temperature from 15°C to 37°C (Fig. 3A). 
Analysis of the SAXS data showed that, in the case of HSPB1, the reduction in the elution 
volume correlated well with an increase in the size of the oligomer as determined from the Rg 
and the molecular weight (Fig. 3B, Supplemental Fig. 2 and Table 1). Specifically the 
observed change in mass resulted in the recruitment of four additional subunits at 37°C, when 
compared to the lower temperature experiments. In the case of HSPB6, despite the dramatic 
increase in the elution volume, the Rg and calculated molecular weight of was similar for all 
experiments (Fig. 3B and Table 1). The measured values are consistent with it preferentially 
being a dimer in solution, as has been previously reported [20,21]. This suggests that at 
elevated temperatures HSPB6 non-specifically associates with the column resin. As this effect 
is temperature-dependent it is likely the result of an increase in HSPB6 hydrophobicity.   
At all measured temperatures, the preheated equimolar mixture of HSPB1 and HSPB6 
showed a clear polydisperse ensemble (Fig. 3A). In comparison to the two sHSPs alone, the 
elution position and absorbance of the maxima of the larger heterooligomeric species 
remained relatively constant, showing that temperature had a smaller effect on the size of this 
entity. This was further confirmed by analysis of the SAXS curves at the peak maxima, which 
suggest the addition of only two subunits over the measured temperature range (Table 1). For 
the smaller tetrameric species, observed as a clear peak at 4 and 15°C, raising the temperature 
to physiological values resulted in a less resolved profile (Figs. 2A and 3A). The relative 
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height of this peak to the larger species reduces, whilst at the same time the overall profile 
becomes more asymmetric showing distinct tailing that extends to later elution volumes (Fig. 
3A and B). This behavior partially mirrors that of HSPB6 alone, suggesting that the smaller 
heterocomplex also becomes more hydrophobic at elevated temperatures resulting in an 
increase in non-specific interaction with the column matrix. Despite the extended elution 
profile comparison of the calculated Rg across the heterooligomer peak were similar at the 
different temperatures (Figs. 2C and 3B).  Importantly, even at the lowest determined values, 
the Rg of the heterooligomer was always greater than that calculated for the dimeric HSPB6 
(Fig. 3B). This suggests that under the studied conditions the complex does not dissociate to 
this smaller building block but rather remains as a tetramer in its smallest form.                           
 
3.3 Native MS analysis shows that HSPB1 and HSPB6 form heterodimers in a preferential 
manner 
We additionally analyzed the heterocomplex between HSPB1 and HSPB6 using native 
MS (Fig. 4). This technique provides an accurate measurement of the molecular mass of the 
species present in the gas phase, and permits analysis of the size and stoichiometry of the 
component entities. Annotation of the spectra showed the prevalence of heterodimeric and 
heterotetrameric populations with a low abundance of higher molecular weight oligomers 
(Fig. 4A). At the 20 たM (0.4 mg/ml) employed the species distribution extends the analysis of 
the effect of protein concentration on oligomer size, initially performed with SAXS-coupled 
SEC (Fig. 2A), showing also a predisposition of the heterooligomer to dissociate into small 
entities at lower concentrations.   
Importantly, careful examination of the MS spectrum of the heterooligomeric mixture 
showed no peaks corresponding to a homodimer of HSPB6 or HSPB1, nor peaks 
corresponding to the larger HSPB1 oligomeric species (Fig. 4A-C). This suggests that 
complete exchange of the individual subunits has occurred forming entities built from a 
HSPB1 and HSPB6 heterodimer. This specific heterodimerisation is surprising, as random 
exchange of the individual protomers would be predicted to lead to oligomers containing a 
mixture of heterodimers and homodimers at equilibrium. Such stochastic exchange was 
observed by native MS analysis of HSPB1 and HSPB6 alone, using mixtures of equimolar 
amounts of 15N-labeled and unlabeled protein (Figs. 4D and E). Following incubation, under 
the same conditions used for heterooligomer formation, the MS spectra of each sHSP showed 
a 1:2:1 ratio of unlabeled homodimer, heterodimer (15N-labeled and unlabeled), and 15N-
labeled homodimer, respectively. Taken together these results demonstrate that when mixed 
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HSPB1 and HSPB6 have a clear preference to form species composed of heterodimers. 
 
3.4 The N-terminal domain is required for preferential heterooligomerization 
 To delineate the necessary regions for this preferential heterodimerization, both 
HSPB1 and HSPB6 were truncated to either the g-crystallin domain (ACD) alone or the ACD 
containing the C-terminal domain (CTD), termed 〉N (Fig. 5).Native MS analysis showed that 
all four constructs alone had the capacity to dimerize (Supplemental Fig. S3).  The truncations 
were therefore analyzed for their capacity to form a heterodimeric complex by this high 
resolution method. For both truncations, heterodimeric species were observed together with 
homo-dimers in an approximate 1:2:1 ratio (Fig. 6A and B, inserts). Although deletion of the 
N-terminal domains (NTDs) does not appear to limit subunit exchange, their removal results 
in a purely stochastic association of the component protomers (Fig. 6).  
 Under the conditions used, monomeric species were also observed in the mass spectra 
for all truncations, suggesting that the NTD-trimmed dimers are less stably associated than the 
full-length proteins. Gas-phase stability assays of the construct mixtures, where the trap 
collision energy was increased by 10 V increments, were performed to assess the relative 
strength of the different dimer interfaces in the gas phase (Fig. 6C and D, Supplemental Fig. 
4). The relative strength of the ACD dimer interface is highly similar for HSPB6, HSPB1 and 
the heterodimer (Fig. 6C). For the 〉N constructs, the presence of the CTD resulted in a 
modest increase in the heterodimer interface strength when compared to the two homodimer 
interfaces (Fig. 6D).  
 Taken together, both the stochastic exchange of subunits and the similar stability of the 
heterodimer interface, show that neither the structured ACD nor the C-terminal regions of the 
two sHSPs have a profound role in the preferential association of full-length HSPB1 and 
HSPB6. The CTD seems to have a mildly stabilizing effect, although it does not seem to 
influence the association of both constructs as the ratio of homo vs. heterodimer was still 
approximately 1:2:1. The determinant region of this heterodimeric association is thus the 






 Heterooligomerization between sHSP orthologues has long been recognized in 
different organisms. Class-specific homologues isolated from some bacteria or plants have 
been demonstrated to associate with each other in vitro [7,8,32]. In vertebrates considerably 
more evidence supports the existence of heterooligomers in vivo. Classically this includes the 
g-crystallins of the eye lens, but numerous other vertebrate sHSPs have been indicated as co-
assembling [6,11]. Typically the interaction between two or more sHSPs appears to be 
stochastic in nature, where the representation of each component in the mixed oligomer 
purely reflects their input concentration [14,22]. However, a number of vertebrate sHSPs have 
been shown to form heterooligomers that contain a fixed ratio of the component protomers, 
independent of the starting proportions used [16,23]. The molecular determinants that define 
such specificity are poorly understood.  
We have characterized the heterooligomers formed between human HSPB1 and 
HSPB6, two sHSPs that are highly expressed in muscle tissue [17]. Together both proteins 
form highly polydisperse assemblies where the predominant species have masses centered at 
283.2 and 76.4 kDa. This profile, as shown previously [23], can be altered by varying the 
concentration of the sHSP mixture, where lower concentrations favor the smaller assembly 
(Fig. 2). This behavior appears to be a combination of the solution properties of the 
component sHSPs. HSPB1 forms large oligomers comprised of close to 30 monomers, 
whereas HSPB6 is predominantly found as a dimer in solution (Table 1). The two major 
species seen for the HSPB1-HSPB6 heterooligomers are both considerably smaller than the 
HSPB1 oligomers, likely an influence of HSPB6. At the same time the smaller 
heterooligomeric entity is principally a tetramer, even at low concentrations, pointing to the 
influence of HSPB1 on assembly. SEC-coupled SAXS analysis of the effect of temperature on 
the species distribution of the heterooligomer showed that raising the sample to physiological 
temperatures resulted in no increase in disassembly of the larger entity. Interestingly the 
tetrameric species demonstrated a non-specific association with the column matrix, similar to 
that of HSPB6 alone, alluding to an increase in hydrophobicity of the parent sHSP and its 
influence on the properties of the smaller heterooligomeric species (Fig. 3). 
The readiness to form smaller assemblies, typically recognized as the active state in 
this family of chaperones [3,4,8], suggest that the HSPB1/HSPB6 heterooligomer may have a 
higher propensity to protect denaturing proteins. Using HEWL, which HSPB6 alone 
completely fails to chaperone, the heterooligomer demonstrated a capacity to prevent 
12 
 
aggregation although not as effectively as HSPB1 (Fig. 1D). With yADH, at higher 
substrate:sHSP ratios, a small increase in activity over the individual sHSPs was observed, 
while with insulin the activity of the heterooligomer was significantly greater than the parent 
sHSPs (Figs. 1C and D). Combined these results show, in the worst case, that the 
heterooligomer has a capacity to chaperone that is equal to the average of the percentage 
protection afforded by HSPB1 and HSPB6 alone. Ultimately though, it does hint at a possible 
enhancement in overall chaperone activity. The observed range of protection is likely a 
limitation of the substrates tested. Future experiments should include an evaluation of more 
biologically relevant proteins, as well as analyzing whether there are differences in substrate 
specificity between the individual sHSPs and their amalgam. 
In order to delineate the sequence determinants that dictate heterooligomer formation 
between these two sHSPs, we have employed nanoelectrospray mass spectrometry. Using 
conditions that maintained the native state, analysis of the heterooligomer clearly showed the 
presence of a heterodimer as the core building block of the larger assemblies (Fig. 4). This 
result is in excellent agreement with disulphide cross-linking experiments that employed a 
double mutant of HSPB6 and the wild-type HSPB1 [11,23]. Crucially in the present study, 
using the wild-type sequence for both proteins, we did not observe any peaks corresponding 
to the homo-dimers of HSPB1 or HSPB6, or higher order assemblies of the former. Thus 
under the conditions employed subunit exchange was complete and biased to heterodimeric 
association. This behavior is different to the two sHSPs alone that demonstrated simple 
stochastic exchange at the monomer level, as observed by the free exchange of heavy and 
light subunits (Fig. 4D an E). 
Structurally a sHSP chain consists of an N-terminal domain (NTD), the central g-
crystallin domain (ACD) and the C-terminal domain (CTD). The ACD has a く-sandwich fold 
and is responsible for dimer formation, while the NTD and CTD are predicted to be 
disordered [20,33]. Limited proteolysis and X-ray crystallographic studies of vertebrate 
sHSPs, point to ACD as being the sole temporally stable structured region in these proteins 
[20,24,34]. This domain, and in particular the く7-strand, forms the principal dimer interface 
between protomers in the higher order assemblies [20,34,35]. It is therefore logical to 
hypothesize that the ACD, and the specific sequence differences in this region between 
HSPB1 and HSPB6, dictate the preferential heterodimerization observed when mixing 
together the two full-length proteins. Surprisingly though the isolated ACDs demonstrated 
stochastic exchange with each other (Fig. 6). Additional gas-phase stability experiments also 
showed that the strength of the ACD dimer interface was similar for both the parent homo-
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dimers and the heterodimer.  Therefore the ACD, although important as the dimerization 
interface, has no role in the preferred association of HSPB1 and HSPB6. 
  Previous studies have demonstrated that the IXI/V motif contained in the CTD can 
influence the strength of the ACD dimer  [36]. Specifically, substitution of the residues 159-
161 of human gB-crystallin with alanines reduced binding of the CTD to the く4/く8 face of the 
ACD and resulted in stabilization of the く7-mediated dimer interface. As HSPB6 does not 
contain the canonical C-terminal IXI/V motif (Fig. 5) it could be rationalized that the mixing 
of this sHSP with HSPB1 would lead to a more stable heterodimer interface, which is indeed 
observed with the 〉N deletion constructs (Fig. 6C and D). Despite this apparent increase in 
the stability of the ACD heterodimer, at equilibrium the overall distribution of the individual 
truncated protomers between homo and heterodimer is still stochastic suggesting that the CTD 
has little to no influence on the preferred association of HSPB1 and HSPB6.   
The various sHSP truncations ultimately point to the NTD, a region predicted to be 
unstructured [20,33], as being essential for driving the specific heterodimerization of HSPB1 
and HSPB6. The involvement of the NTD in defining the heterodimer interface, located at the 
ACD, is quite remarkable. Truncation or post-translational modification of this region often 
leads to smaller assemblies typically pointing to its recognized role in higher-order 
oligomerization rather than dimer formation [33]. It was reported that phosphorylation of the 
N-terminal serine residues of HSPB5 led to a loss of the dimeric substructure within the larger 
oligomer species, but this was hypothesized to be the result of a reduced interaction of 
individual subunits within the whole assembly [37].  
 In the present study, the NTDs appear to have a role in stabilizing the smaller 
heterodimer containing species, most clearly seen by the absence of monomers in the native 
MS analysis of the full-length heterodimeric protein compared to the two truncations under 
identical conditions (Figs. 4 and 5). This suggests the possibility of cross-talk between one or 
both of the NTDs and the heterodimer ACD, via a molecular mechanism that is absent in the 
homo-oligomeric species. Future experiments should attempt to discern the specific sequence 
epitopes that define this interaction, which appears non-trivial due to poor sequence 
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Figure  legends 
 
Fig. 1. Characterization of the HSPB1-HSPB6 heterooligomer. (A) Analytical gel-filtration 
profile of an equimolar mixture of HSPB1 and HSPB6 loaded directly onto the column after 
mixing at 4°C (black curve), or following overnight incubation at 37°C (grey dashed curve). A 
100 μl sample was loaded onto a Superdex 200 10/300 column equilibrated in 20 mM 
HEPES, 150 mM NaCl and 2.5 mM DTT. Eluted fraction positions are labeled above the 
abscissa. (B) SDS-PAGE analysis of the fractions from analytical gel-filtration. Fraction 
numbers above the gel correspond to panel A. An input sample (i) of the equimolar mix of 
both sHSPS taken prior to injection onto the column, and the same sample diluted 10-fold 
(i/10) were also loaded. (C-E) Chaperone activity of the heterooligomeric complex compared 
to B1 and B6 alone. Aggregation was monitored by following the absorbance at 340 nm for 
90 min. The percentage of protection for each construct was calculated as described in 
Materials and Methods. (C) 0.25 mg/ml insulin incubated with HSPB1 or HSPB6 alone or the 
HSPB1-HSPB6 complex. Aggregation was induced by addition of 10 mM DTT (final 
concentration) prior to continuous measurement at 37°C. The ratios of substrate to sHSP are 
1:0.2 (black bars), 1:0.1 (gray bars) and 1:0.05 (light gray bars). (D) 0.25 mg/ml yADH as 
substrate. Aggregation was induced by the addition of 20 mM DTT and 2 mM EDTA (final 
concentrations) prior to measurement at 42°C. The ratios used are 1:2 (black bars), 1:1 (gray 
bars) and 1:0.5 (light gray bars). (E) Time dependent aggregation of HEWL. Following 
preincubation at 37°C aggregation was induced by addition of 10 mM DTT (final 
concentration). 0.25 mg/ml of HEWL was used as a substrate in a 1:2 monomer molar ratio 
with the specified sHSP. 
 
Fig. 2. SEC-coupled SAXS analysis of the HSPB1-HSPB6 heterooligomer (A) UV based 
chromatogram showing the effect of the loaded sample concentration on the species 
distribution of an equimolar mixture of HSPB1 and HSPB6. The mixed sHSPs were pre-
incubated overnight at 37°C. The highest concentration sample was then appropriately diluted 
in 20 mM Hepes pH 7.4, 150 mM NaCl and 2.5 mM DTT. 25 たl of each sample was loaded 
onto an analytical Agilent Bio SEC-3 column pre-equilibrated in the same buffer. The column 
temperature was maintained at 15°C. (B) The corresponding SAXS intensity profiles (lines) 
normalized by the maxima (Cmax) of the UV-chromatogram (see the Methods for a full 
definition of the value plotted). The calculated radius of gyration (Rg) across the eluting peak 
for each concentration is represented as dots. For clarity only every other point is plotted. 
217.5 μg (red line and dots), 108.8 μg (black lines and dots), 54.5 μg (blue lines and dots). 
(C) Gaussian decomposition of the intensity profile of the 108.8 μg loaded sample. The 
measured intensities and calculated Rg across the whole peak are are shown in black lines and 
dots, respectively. The two skewed Gaussian fits (blue and cyan) and their sum (red) are 
shown overlaying the intensity data. The corresponding calculated Rg across the decomposed 
peaks are shown in the same colours. 
 
Fig. 3. Effect of temperature on HSPB1 and HSPB6 and their heterooligomeric complexes 
(A) Overlaid UV chromatograms of SEC runs of HSPB1 and HSPB6 alone and their 
equimolar mixture at various temperatures. The mixed sHSPs were pre-incubated overnight at 
37°C. 25 たl of each sample was loaded onto an analytical Agilent Bio SEC-3 column pre-
equilibrated in 20 mM Hepes pH 7.4, 150 mM NaCl and 2.5 mM DTT. Both the autosampler 
and the column were pre-incubated at the stated temperatures for 30 minutes before 
application of the sample. The vertical dashed lines correspond to the maxima position for 
HSPB1 and HSPB6 at 15°C. (B) Overlaid SAXS intensity profiles of HSPB1 at 15°C (dashed 
red line) and 30°C (red line), HSPB6 at 15°C (dashed blue line) and 30°C (blue line), and the 
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heterooligomeric mix at 30°C (black line). The corresponding Rg for each peak are shown as 
empty (15°C) or filled (30°C) circles in the same colour as the respective intensity plot. 
 
Fig. 4. Native mass spectrometry analysis of HSPB1, HSPB6 and their heterooligomeric 
complexes. Annotated spectra from native MS of the HSPB1-HSPB6 heterocomplex (A), 
HSPB1 (B) and HSPB6 (C). For each sample an equivalent of 20 μM monomer concentration 
of protein, diluted in 200 mM ammonium acetate pH 6.9 containing 2.5 mM DTT, was 
analyzed on a Synapt G2 HDMS (Waters). Charge states and the species identity are indicated 
above each peak.  The number of circles above the annotated peaks corresponds to the 
oligomeric state of the identified species. (D) A zoom in of the 13+ charge state from the 
native MS profile of HSPB1 that had been pre-mixed with equimolar amounts of 15N-labeled 
HSPB1. (E) A zoom of the 11+ charge state from the native MS profile of HSPB6 pre-mixed 
with equimolar amounts of 15N-labeled HSPB6. 
 
Fig. 5. HSPB1 and HSPB6 deletion constructs. The different sHSP truncations, and their 
residue ranges, are shown relative to the corresponding full-length protein. Domain 
boundaries for the ACD are based on X-ray crystal structures [33].  The NTD and CTD for 
both constructs are shaded in gray. The sequence and position of the highly conserved C-
terminal IXI/V motif is shown for HSPB1.   
 
Fig. 6. Native mass spectrometry analysis of truncated HSPB1 and HSPB6 constructs. (A) 
Native MS of the heterooligomeric mixture of HSPB1.ACD and HSPB6.ACD in a 1:1 ratio. 
(B) Native MS of the heterooligomeric mixture of HSPB1.〉N and HSPB6.〉N in a 1:1 ratio. 
(C) Graph showing the results of the gas-phase stability assay where the trap collision energy 
was increased with 10 V increments on the sample containing the equimolar mixture of 
HSPB1.ACD and HSPB6.ACD (orange line), HSPB1.ACD alone (red line) and HSPB6.ACD 
alone (green line). (D) Graph showing the results of the gas-phase stability assay where the 
trap collision energy was increased with 10 V increments on the sample containing the 
equimolar mixture of HSPB1.〉N and HSPB6.〉N (orange line), HSPB1.〉N (red line) alone 
and HSPB6.〉N alone (green line). Inserts in panels (A) and (B) show relative abundances of 
the different homo- and heterodimers as determined after spectral deconvolution. Normalized 
collision energies in panels (C) and (D) were calculated according to standard procedures 









Table 1. Molecular weight estimates of species at the SEC-coupled SAXS scattering maxima.   
 HSPB1 HSPB6 HSPB1/HSPB6 
Temperature (°C) Mra Subunits Mr Subunits Mr Subunitsb 
15 540.0 24 37.0 2 258.4 13 
20 553.4 24 37.7 2 263.9 13 
30 573.3 25 45.8 3 292.2 15 
37 643.9 28 38.7 2 293.4 15 
a The molecular weight was calculated from the QR value [30], determined from the averaged 
SAXS scattering curve.    
bAn average molecular weight of 20.0 kDa was used for calculation of the number of subunits 
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